Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China's Dehaier appoints chief technology officer

This article was originally published in Clinica

Executive Summary

Dehaier Medical Systems, a Chinese manufacturer of respiratory and oxygen homecare devices, has appointed Xiaoqing Wang chief technology officer. Dr Wang has over 20 years of biomedical engineering experience: before joining Dehaier, he was director of the Beijing Taijie Magneto-electrical Institute, which develops nuclear magnetic resonance technology, for six years. Before this, he was chief engineer of Beijing Wandong Medical Equipment, China's largest medical equipment manufacturer. Dr Wang replaces Yong Wang, who resigned from the position after eight years due to personal reasons, according to the company. Beijing-based Dehaier develops and assembles its own brand devices and homecare products from third-party components, and also distributes products developed by other companies including US firm Welch Allyn and Germany's Heyer Medical. Dehaier is currently looking for partners that wish to expand their business in China.

You may also be interested in...



What are the hottest innovations from Israel?

Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.

EuroPCR: St Jude and Philips talk up rival intravascular imaging techs

St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.

EuroPCR: Medtronic's drug-coated balloon keeps rising

A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT097593

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel